{"id": "397488", "url": "https://fevir.net/resources/Composition/397488", "date": "2025-09-03T12:20:32.624Z", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/summary-of-findings"], "versionId": "9", "lastUpdated": "2025-09-03T12:20:32.624Z"}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><table><tbody><tr><th><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>Outcome</p></div></th><th><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>Sample Size</p></div></th><th><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>Result Without Treatment</p></div></th><th><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>Result With Treatment (Observed)</p></div></th><th><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>Result With Treatment (Calculated)</p></div></th><th><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>Effect Estimate</p></div></th><th><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>Certainty of Evidence</p></div></th><th><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>What this means</p></div></th></tr><tr><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>Systolic blood pressure at 12 weeks</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>62 participants, 60 analyzed, 53 without missing data</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>difference in means -4.5 mm Hg (95% confidence interval -10.82 mm Hg to 1.32 mm Hg)</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td></tr><tr><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>Diastolic blood pressure at 12 weeks</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>62 participants, 60 analyzed, 53 without missing data</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>[Not a proportion.]</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>difference in means -4.92 mm Hg (95% confidence interval -8.58 mm Hg to 0.27 mm Hg)</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td></tr><tr><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>Medication Adherence at 12 weeks</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>62 participants, 53 without missing data</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>70%</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>65.6%</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>46.33%</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>odds ratio 0.37 (95% confidence interval 0.19 to 2.08)</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td></tr><tr><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>Hypertension Control at 12 weeks</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>62 participants, 60 analyzed, 53 without missing data</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>54.17%</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>65.52%</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>77.11%</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>odds ratio 2.85 (95% confidence interval 0.94 to 8.59)</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td></tr><tr><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>Add-on Amlodipine at 6 weeks</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>62 participants, 60 analyzed, 62 without missing data, 22 events</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>53.33%</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>18.75%</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>51.25%</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>odds ratio 0.92 (95% confidence interval 0.02 to 0.41)</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td></tr><tr><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>Adverse event free and hypertension control at 12 weeks</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>62 participants, 53 analyzed, 53 without missing data, 13 events</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>33.33%</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>17.24%</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>29.33%</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>odds ratio 0.83 (95% confidence interval 0.22 to 3.16)</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td></tr></tbody></table></div>", "status": "additional"}, "type": {"text": "Summary of Findings", "coding": [{"code": "SummaryOfFindings", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "SummaryOfFindings"}]}, "title": "Summary of Findings - QUARTET USA Trial", "author": [{"display": "Brian S. Alper, MD, MSPH"}], "status": "final", "custodian": {"type": "Organization", "display": "Computable Publishing LLC", "reference": "Organization/118079"}, "relatesTo": [{"type": "derived-from", "targetReference": {"type": "Composition", "display": "Outcome Measure Report for QUARTET USA Trial", "reference": "Composition/375280"}}, {"type": "cite-as", "targetMarkdown": "Summary of Findings - QUARTET USA Trial [Database Entry: FHIR Composition Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 397488. Revised 2025-09-03. Available at: https://fevir.net/resources/Composition/397488. Computable resource at: https://fevir.net/resources/Composition/397488."}], "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "value": "397488", "system": "https://fevir.net/FOI", "assigner": {"display": "Computable Publishing LLC"}}], "resourceType": "Composition", "section": [{"code": {"coding": [{"code": "column-headers", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Column Headers"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">No need for narrative text.</div>", "status": "empty"}, "title": "Column Headers", "section": [{"code": {"coding": [{"code": "outcome-measure", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Outcome Measure"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Outcome</p></div>", "status": "generated"}, "title": "Outcome Measure"}, {"code": {"coding": [{"code": "sample-size", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Sample Size"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Sample Size</p></div>", "status": "generated"}, "title": "Sample Size"}, {"code": {"coding": [{"code": "result-with-comparator-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with comparator alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Result Without Treatment</p></div>", "status": "generated"}, "title": "Result Without Treatment"}, {"code": {"coding": [{"code": "result-with-intervention-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Result With Treatment (Observed)</p></div>", "status": "generated"}, "title": "Result With Treatment--Observed"}, {"code": {"text": "result with intervention with calculated value derived from the control group and effect estimate", "coding": [{"code": "result-with-intervention-alone-calculated", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone (calculated)"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Result With Treatment (Calculated)</p></div>", "status": "generated"}, "title": "Result With Treatment--Derived"}, {"code": {"coding": [{"code": "result-with-intervention-vs-comparator", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention vs. comparator"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Effect Estimate</p></div>", "status": "generated"}, "title": "Effect Estimate"}, {"code": {"coding": [{"code": "certainty-of-evidence", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Certainty of Evidence"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Certainty of Evidence</p></div>", "status": "generated"}, "title": "Certainty of Evidence"}, {"code": {"coding": [{"code": "assertion", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Assertion"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>What this means</p></div>", "status": "generated"}, "title": "Assertion"}]}, {"code": {"coding": [{"code": "summary-of-findings", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Summary of Findings"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>", "status": "empty"}, "title": "Summary of Findings", "section": [{"code": {"coding": [{"code": "summary-of-findings-entry-for-a-single-outcome", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"type": "EvidenceVariable", "display": "Systolic blood pressure at 12 weeks", "reference": "EvidenceVariable/375185"}, "title": "Results for Systolic blood pressure at 12 weeks", "section": [{"code": {"coding": [{"code": "outcome-measure", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Outcome Measure"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Systolic blood pressure at 12 weeks</p></div>", "status": "generated"}, "entry": [{"type": "EvidenceVariable", "display": "Systolic blood pressure at 12 weeks", "reference": "EvidenceVariable/375185"}], "title": "Outcome Measure"}, {"code": {"coding": [{"code": "sample-size", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Sample Size"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>62 participants, 60 analyzed, 53 without missing data</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Systolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan", "reference": "Evidence/397483"}], "title": "Sample Size"}, {"code": {"coding": [{"code": "result-with-comparator-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with comparator alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a proportion.]</p></div>", "status": "empty"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Systolic blood pressure at 12 weeks in QUARTET USA Trial Control Group", "reference": "Evidence/375594"}], "title": "Result Without Treatment"}, {"code": {"coding": [{"code": "result-with-intervention-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a proportion.]</p></div>", "status": "empty"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Systolic blood pressure at 12 weeks in QUARTET USA Trial Quadpill group", "reference": "Evidence/375628"}], "title": "Result With Treatment--Observed"}, {"code": {"text": "result with intervention with calculated value derived from the control group and effect estimate", "coding": [{"code": "result-with-intervention-alone-calculated", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone (calculated)"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>", "status": "empty"}, "title": "Result With Treatment--Derived"}, {"code": {"coding": [{"code": "result-with-intervention-vs-comparator", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention vs. comparator"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>difference in means -4.5 mm Hg (95% confidence interval -10.82 mm Hg to 1.32 mm Hg)</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Systolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan", "reference": "Evidence/397483"}], "title": "Effect Estimate"}, {"code": {"coding": [{"code": "certainty-of-evidence", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Certainty of Evidence"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No certainty rating found.]</p></div>", "status": "empty"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Systolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan", "reference": "Evidence/397483"}], "title": "Certainty of Evidence"}, {"code": {"coding": [{"code": "assertion", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Assertion"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No assertion provided.]</p></div>", "status": "empty"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Systolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan", "reference": "Evidence/397483"}], "title": "Assertion"}]}, {"code": {"coding": [{"code": "summary-of-findings-entry-for-a-single-outcome", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"type": "EvidenceVariable", "display": "Diastolic blood pressure at 12 weeks", "reference": "EvidenceVariable/375186"}, "title": "Results for Diastolic blood pressure at 12 weeks", "section": [{"code": {"coding": [{"code": "outcome-measure", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Outcome Measure"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Diastolic blood pressure at 12 weeks</p></div>", "status": "generated"}, "entry": [{"type": "EvidenceVariable", "display": "Diastolic blood pressure at 12 weeks", "reference": "EvidenceVariable/375186"}], "title": "Outcome Measure"}, {"code": {"coding": [{"code": "sample-size", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Sample Size"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>62 participants, 60 analyzed, 53 without missing data</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Diastolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan", "reference": "Evidence/397482"}], "title": "Sample Size"}, {"code": {"coding": [{"code": "result-with-comparator-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with comparator alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a proportion.]</p></div>", "status": "empty"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Diastolic blood pressure at 12 weeks in QUARTET USA Trial Control Group", "reference": "Evidence/375932"}], "title": "Result Without Treatment"}, {"code": {"coding": [{"code": "result-with-intervention-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a proportion.]</p></div>", "status": "empty"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Diastolic blood pressure at 12 weeks in QUARTET USA Trial Quadpill group", "reference": "Evidence/375629"}], "title": "Result With Treatment--Observed"}, {"code": {"text": "result with intervention with calculated value derived from the control group and effect estimate", "coding": [{"code": "result-with-intervention-alone-calculated", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone (calculated)"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>", "status": "empty"}, "title": "Result With Treatment--Derived"}, {"code": {"coding": [{"code": "result-with-intervention-vs-comparator", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention vs. comparator"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>difference in means -4.92 mm Hg (95% confidence interval -8.58 mm Hg to 0.27 mm Hg)</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Diastolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan", "reference": "Evidence/397482"}], "title": "Effect Estimate"}, {"code": {"coding": [{"code": "certainty-of-evidence", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Certainty of Evidence"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No certainty rating found.]</p></div>", "status": "empty"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Diastolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan", "reference": "Evidence/397482"}], "title": "Certainty of Evidence"}, {"code": {"coding": [{"code": "assertion", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Assertion"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No assertion provided.]</p></div>", "status": "empty"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Diastolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan", "reference": "Evidence/397482"}], "title": "Assertion"}]}, {"code": {"coding": [{"code": "summary-of-findings-entry-for-a-single-outcome", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Summary of findings entry for a single outcome"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>", "status": "empty"}, "focus": {"type": "EvidenceVariable", "display": "Medication Adherence at 12 weeks", "reference": "EvidenceVariable/375201"}, "title": "Results for Medication Adherence at 12 weeks", "section": [{"code": {"coding": [{"code": "outcome-measure", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Outcome Measure"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Medication Adherence at 12 weeks</p></div>", "status": "generated"}, "entry": [{"type": "EvidenceVariable", "display": "Medication Adherence at 12 weeks", "reference": "EvidenceVariable/375201"}], "title": "Outcome Measure"}, {"code": {"coding": [{"code": "sample-size", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Sample Size"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>62 participants, 53 without missing data</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Medication Adherence at 12 weeks in GroupAssignment: Quadpill vs. Candesartan", "reference": "Evidence/397481"}], "title": "Sample Size"}, {"code": {"coding": [{"code": "result-with-comparator-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with comparator alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>70%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Medication Adherence at 12 weeks in QUARTET USA Trial Control Group", "reference": "Evidence/379724"}], "title": "Result Without Treatment"}, {"code": {"coding": [{"code": "result-with-intervention-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>65.6%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Medication Adherence at 12 weeks in QUARTET USA Trial Quadpill group", "reference": "Evidence/379723"}], "title": "Result With Treatment--Observed"}, {"code": {"text": "result with intervention with calculated value derived from the control group and effect estimate", "coding": [{"code": "result-with-intervention-alone-calculated", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone (calculated)"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>", "status": "empty"}, "title": "Result With Treatment--Derived"}, {"code": {"coding": [{"code": "result-with-intervention-vs-comparator", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention vs. comparator"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>odds ratio 0.37 (95% confidence interval 0.19 to 2.08)</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Medication Adherence at 12 weeks in GroupAssignment: Quadpill vs. Candesartan", "reference": "Evidence/397481"}], "title": "Effect Estimate"}, {"code": {"coding": [{"code": "certainty-of-evidence", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Certainty of Evidence"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No certainty rating found.]</p></div>", "status": "empty"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Medication Adherence at 12 weeks in GroupAssignment: Quadpill vs. Candesartan", "reference": "Evidence/397481"}], "title": "Certainty of Evidence"}, {"code": {"coding": [{"code": "assertion", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Assertion"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No assertion provided.]</p></div>", "status": "empty"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Medication Adherence at 12 weeks in GroupAssignment: Quadpill vs. Candesartan", "reference": "Evidence/397481"}], "title": "Assertion"}]}, {"code": {"coding": [{"code": "summary-of-findings-entry-for-a-single-outcome", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"type": "EvidenceVariable", "display": "Hypertension Control at 12 weeks", "reference": "EvidenceVariable/375202"}, "title": "Results for Hypertension Control at 12 weeks", "section": [{"code": {"coding": [{"code": "outcome-measure", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Outcome Measure"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Hypertension Control at 12 weeks</p></div>", "status": "generated"}, "entry": [{"type": "EvidenceVariable", "display": "Hypertension Control at 12 weeks", "reference": "EvidenceVariable/375202"}], "title": "Outcome Measure"}, {"code": {"coding": [{"code": "sample-size", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Sample Size"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>62 participants, 60 analyzed, 53 without missing data</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Hypertension Control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan", "reference": "Evidence/397480"}], "title": "Sample Size"}, {"code": {"coding": [{"code": "result-with-comparator-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with comparator alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>54.17%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Hypertension Control at 12 weeks in QUARTET USA Trial Control Group", "reference": "Evidence/379737"}], "title": "Result Without Treatment"}, {"code": {"coding": [{"code": "result-with-intervention-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>65.52%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Hypertension Control at 12 weeks in QUARTET USA Trial Quadpill group", "reference": "Evidence/379736"}], "title": "Result With Treatment--Observed"}, {"code": {"text": "result with intervention with calculated value derived from the control group and effect estimate", "coding": [{"code": "result-with-intervention-alone-calculated", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone (calculated)"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>", "status": "empty"}, "title": "Result With Treatment--Derived"}, {"code": {"coding": [{"code": "result-with-intervention-vs-comparator", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention vs. comparator"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>odds ratio 2.85 (95% confidence interval 0.94 to 8.59)</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Hypertension Control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan", "reference": "Evidence/397480"}], "title": "Effect Estimate"}, {"code": {"coding": [{"code": "certainty-of-evidence", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Certainty of Evidence"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No certainty rating found.]</p></div>", "status": "empty"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Hypertension Control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan", "reference": "Evidence/397480"}], "title": "Certainty of Evidence"}, {"code": {"coding": [{"code": "assertion", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Assertion"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No assertion provided.]</p></div>", "status": "empty"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Hypertension Control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan", "reference": "Evidence/397480"}], "title": "Assertion"}]}, {"code": {"coding": [{"code": "summary-of-findings-entry-for-a-single-outcome", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"type": "EvidenceVariable", "display": "Add-on Amlodipine at 6 weeks", "reference": "EvidenceVariable/375203"}, "title": "Results for Add-on Amlodipine at 6 weeks", "section": [{"code": {"coding": [{"code": "outcome-measure", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Outcome Measure"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Add-on Amlodipine at 6 weeks</p></div>", "status": "generated"}, "entry": [{"type": "EvidenceVariable", "display": "Add-on Amlodipine at 6 weeks", "reference": "EvidenceVariable/375203"}], "title": "Outcome Measure"}, {"code": {"coding": [{"code": "sample-size", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Sample Size"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>62 participants, 60 analyzed, 62 without missing data, 22 events</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Add-on Amlodipine at 6 weeks in GroupAssignment: Quadpill vs. Candesartan", "reference": "Evidence/397479"}], "title": "Sample Size"}, {"code": {"coding": [{"code": "result-with-comparator-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with comparator alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>53.33%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Add-on Amlodipine at 6 weeks in QUARTET USA Trial Control Group", "reference": "Evidence/379740"}], "title": "Result Without Treatment"}, {"code": {"coding": [{"code": "result-with-intervention-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>18.75%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Add-on Amlodipine at 6 weeks in QUARTET USA Trial Quadpill group", "reference": "Evidence/379739"}], "title": "Result With Treatment--Observed"}, {"code": {"text": "result with intervention with calculated value derived from the control group and effect estimate", "coding": [{"code": "result-with-intervention-alone-calculated", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone (calculated)"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>", "status": "empty"}, "title": "Result With Treatment--Derived"}, {"code": {"coding": [{"code": "result-with-intervention-vs-comparator", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention vs. comparator"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>odds ratio 0.92 (95% confidence interval 0.02 to 0.41)</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Add-on Amlodipine at 6 weeks in GroupAssignment: Quadpill vs. Candesartan", "reference": "Evidence/397479"}], "title": "Effect Estimate"}, {"code": {"coding": [{"code": "certainty-of-evidence", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Certainty of Evidence"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No certainty rating found.]</p></div>", "status": "empty"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Add-on Amlodipine at 6 weeks in GroupAssignment: Quadpill vs. Candesartan", "reference": "Evidence/397479"}], "title": "Certainty of Evidence"}, {"code": {"coding": [{"code": "assertion", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Assertion"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No assertion provided.]</p></div>", "status": "empty"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Add-on Amlodipine at 6 weeks in GroupAssignment: Quadpill vs. Candesartan", "reference": "Evidence/397479"}], "title": "Assertion"}]}, {"code": {"coding": [{"code": "summary-of-findings-entry-for-a-single-outcome", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"type": "EvidenceVariable", "display": "Adverse event free and hypertension control at 12 weeks", "reference": "EvidenceVariable/375278"}, "title": "Results for Adverse event free and hypertension control at 12 weeks", "section": [{"code": {"coding": [{"code": "outcome-measure", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Outcome Measure"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Adverse event free and hypertension control at 12 weeks</p></div>", "status": "generated"}, "entry": [{"type": "EvidenceVariable", "display": "Adverse event free and hypertension control at 12 weeks", "reference": "EvidenceVariable/375278"}], "title": "Outcome Measure"}, {"code": {"coding": [{"code": "sample-size", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Sample Size"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>62 participants, 53 analyzed, 53 without missing data, 13 events</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Adverse event free and hypertension control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan", "reference": "Evidence/397478"}], "title": "Sample Size"}, {"code": {"coding": [{"code": "result-with-comparator-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with comparator alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>33.33%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Adverse event free and hypertension control at 12 weeks in QUARTET USA Trial Control Group", "reference": "Evidence/379743"}], "title": "Result Without Treatment"}, {"code": {"coding": [{"code": "result-with-intervention-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>17.24%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Adverse event free and hypertension control at 12 weeks in QUARTET USA Trial Quadpill group", "reference": "Evidence/379742"}], "title": "Result With Treatment--Observed"}, {"code": {"text": "result with intervention with calculated value derived from the control group and effect estimate", "coding": [{"code": "result-with-intervention-alone-calculated", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone (calculated)"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>", "status": "empty"}, "title": "Result With Treatment--Derived"}, {"code": {"coding": [{"code": "result-with-intervention-vs-comparator", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention vs. comparator"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>odds ratio 0.83 (95% confidence interval 0.22 to 3.16)</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Adverse event free and hypertension control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan", "reference": "Evidence/397478"}], "title": "Effect Estimate"}, {"code": {"coding": [{"code": "certainty-of-evidence", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Certainty of Evidence"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No certainty rating found.]</p></div>", "status": "empty"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Adverse event free and hypertension control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan", "reference": "Evidence/397478"}], "title": "Certainty of Evidence"}, {"code": {"coding": [{"code": "assertion", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Assertion"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No assertion provided.]</p></div>", "status": "empty"}, "entry": [{"type": "Evidence", "display": "Evidence for Results for Adverse event free and hypertension control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan", "reference": "Evidence/397478"}], "title": "Assertion"}]}]}]}